Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03978611
Title A Study to Assess Safety and Efficacy of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-PD-1 Treatment
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Local Institution - 0023 Tucson Arizona 85724 United States Details
Local Institution - 0002 Los Angeles California 90033 United States Details
Local Institution - 0005 Los Angeles California 90033 United States Details
Local Institution - 0001 Santa Monica California 90404 United States Details
Local Institution - 0015 Miami Florida 33136 United States Details
Local Institution - 0004 Chicago Illinois 60611 United States Details
Local Institution - 0003 Ann Arbor Michigan 48109 United States Details
Local Institution - 0008 Morristown New Jersey 07960 United States Details
Local Institution - 0018 Bruxelles Brussels 1000 Belgium Details
Local Institution - 0017 Antwerpen 2020 Belgium Details
Local Institution - 0016 Brussels 1090 Belgium Details
Local Institution - 0038 Bruxelles 1200 Belgium Details
Local Institution - 0044 Ottawa Ontario K1H 8L6 Canada Details
Local Institution - 0048 Bordeaux 33075 France Details
Local Institution - 0022 Lyon 69008 France Details
Local Institution - 0021 Marseille Cedex 5 13385 France Details
Local Institution - 0020 Nantes 44000 France Details
Local Institution - 0037 Erlangen 91054 Germany Details
Local Institution - 0034 Essen 45147 Germany Details
Local Institution - 0036 Gera 07548 Germany Details
Local Institution - 0035 Hannover 30625 Germany Details
Local Institution - 0033 Heidelberg 69120 Germany Details
Local Institution - 0032 Lübeck 23562 Germany Details
Local Institution - 0040 Nuremberg 90419 Germany Details
Local Institution - 0026 Barcelona 08035 Spain Details
Local Institution - 0030 Cordoba 14004 Spain Details
Local Institution - 0027 Hospitalet de Llobregat - Barcelona 08908 Spain Details
Local Institution - 0029 Madrid 28034 Spain Details
Local Institution - 0031 San Sebastian 20014 Spain Details
Local Institution - 0028 Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field